期刊
MOLECULAR MEDICINE REPORTS
卷 16, 期 5, 页码 6890-6895出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2017.7406
关键词
brassinin; human umbilical vein endothelial cells; tumor necrosis factor-alpha; vascular inflammation; atherosclerosis
资金
- National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea [2008-0062484]
Brassinin, a phytoalexin firstly identified as a constituent of Chinese cabbage, has been demonstrated to exhibit antiproliferative effects on various cancer cell lines, by reducing reactive oxygen species (ROS) production via regulation of the antioxidant pathway. The present study aimed to explore the protective effects of brassinin in TNF-alpha-induced vascular inflammation in human umbilical vein endothelial cells (HUVECs). Pretreatment with brassinin significantly inhibited adhesion of U937 cells to TNF-alpha-induced HUVECs in a dose-dependent manner. Brassinin treatment decreased the expression levels of cell adhesion molecules, including intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial-selectin (E-selectin) following stimulation with TNF-a in HUVECs. In addition, pretreatment with brassinin decreased the protein expression levels of nuclear factor (NF) -.B p65 in the nucleus, suggesting that brassinin inhibited NF-kappa B p65 nuclear translocation. Brassinin treatment also markedly decreased the mRNA expression levels of interleukin-8 in a dose-dependent manner. Finally, brassinin pretreatment significantly decreased TNF-alpha-induced intracellular reactive oxygen species (ROS) production in HUVECs compared with control. The present results therefore suggest that brassinin may serve as a potential therapeutic agent for atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据